Algorithmic Culture | Magazine

  • home
  • about
  • masthead
  • contact
  • podcast
  • home
  • about
  • masthead
  • contact
  • podcast

Algorithmic Culture | Magazine

Home>GlaxoSmithKline

GlaxoSmithKline

With A Possibility For CRISPR To Cure “All” Diseases, Should All New Biotech Companies Be Designated Public Benefit Corporations (PBCs) To Thwart Potentially Specious Big Pharma Takeovers?
March 23, 2020October 16, 2020

With A Possibility For CRISPR To Cure “All” Diseases, Should All New Biotech Companies Be Designated Public Benefit Corporations (PBCs) To Thwart Potentially Specious Big Pharma Takeovers?

A neoteric philosophy on CRISPR (Cas9 and other variants): biotech startups; takeovers; Big Pharma (potentially comprised with executives susceptible to unscrupulous profit motives); a designate known as 'PBC'; and China. It…

Read More
Copyright 2017-2023 © Algorithmic Culture | Magazine The material on this site may not be reproduced, disseminated, cached, transmitted or otherwise used without the prior written consent of Algorithmic Culture.